In the News

Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  

Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice

Leadership change at Providence Cancer Institute, #FINISHCANCER goal remains

11/14/2024

R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.

2024 SITC Meeting: A glimpse of recent advancements in immunotherapy

11/19/2024

The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.

Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

10/30/2024

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

New studies test immunotherapy to boost breast cancer treatment and prevent return

10/30/2024

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

Attend a free virtual symposium on melanoma, Oct. 25

10/8/2024

Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.

Prostate cancer study includes a tumor test to personalize treatment

9/27/2024

A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.

Meet physician scientist, Dr. Allie Grossmann

9/23/2024

Dr. Allie Grossmann’s new lab at Earle A. Chiles Research Institute is focused on understanding how tumors communicate with their environment, grow, survive and spread.

Dr. Walter Urba announces retirement from Providence

8/22/2024

Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.

Dr. Bernard Fox honored for his lifetime contributions to cancer research

8/23/2024

Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.

Can these new studies offer hope for people with lung and head and neck cancers?

8/27/2024

A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.

Cancer survivor speaks with doctor he credits for saving his life

8/27/2024

Cancer survivor Mark Williams chats with Dr. Brendan Curti about

2024 Hood to Coast Relay: Providence team captains tell us why they run

8/22/2024

What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.

Promising advances in treating TNBC: Two studies offer hope

7/31/2024

Although chemotherapy is the cornerstone treatment for triple negative breast cancer, survival outcomes remain disappointing. Two studies could help improve treatment options.

Targeting cancer cells: Two studies take different approaches

6/26/2024

A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

The evolution of cancer immunotherapy: Dr. Urba shares his insights

6/28/2024

Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

Cancer survivorship: A guide to living with and beyond cancer

6/11/2024

June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer

Radiation oncologist discusses MRI-guided radiation therapy for pancreatic cancer

8/9/2024

Providence Cancer Institute presented a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.

Providence researchers contribute study findings at ASCO 2024 meeting, May 31- June 3

6/10/2024

The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.

With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model

6/3/2024

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.

2023 research report highlights breadth and impact of research at Providence

5/20/2024

Providence researchers conducted over 2400 studies in 2023, according to the 2023 Providence Research Network Annual Report

Cancer studies seek to harness the power of the immune system

5/29/2024

Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.

Celebrating World Immunology Day

4/26/2024

Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.

New vaccine being studied for HPV+ head and neck cancer

5/7/2024

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

Looking ahead: Growth and advancements in surgical oncology at Providence Cancer Institute

4/3/2024

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

Celebrating our oncology social workers

3/25/2024

In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.

Talking to an expert: The crucial role of nutrition in cancer care

3/19/2024

In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.

How promoting apoptosis in new study may help people with cancer

3/21/2024

In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.

Dose-escalation studies aspire to fill gaps in cancer treatment options

2/26/2024

Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.

FDA approves cellular therapy, offering hope to more people with cancer

3/6/2024

The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).